代表性论文 |
发表SCI论文30余篇，近3年发表SCI论文如下： [1] [1]. Zheng W, Zhao J, Tao Y, Guo M, Zhou Y, Chen C, Qin N, Zheng J, Luo J,Xu L*MicroRNA-21: a promising biomarker for prognosis and diagnosis of non-small cell lung cancer. Onco Lett. 2017. ** [2] [2]. Lei L, Chen C, Zhao J, Wang H, Guo M, Zhou Y, Luo J, Zhang J,Xu L*.Targeted expression of miR-7 operated by TTF-1 promoter inhibited the growth of human lung cancer through NDUFA4 pathway. Mol Ther Nucleic Acids, 2017, 6(3):183-197. ** [3] [3]. Zhao J, Chen C, Guo M, Tao Y, Cui P, Zhou Y, Qin N, Zheng J, Zhang J,Xu L*.MicroRNA-7 deficiency ameliorates the pathologies of Acute Lung Injury through Elevating KLF4. Front Immunol, 2016, 7:389. ** [4] [4]. Zhao J, Tao Y, Zhou Y,Qin N, Chen C, Tian D,Xu L*. MicroRNA-7: A Promising New Target in Cancer Therapy. Canc Cell Int, 2015,15:103. ** [5] [5]. Zhao JJ, Wang, Kl, Liao ZY, Li Y, Yang H, Chen C, Zhou Y, Tao YJ, Guo MM, Ren T,Xu L*. Promoter mutation of tumor suppressor gene MicroRNA-7 was related to poor prognosis of lung cancer. Mol Clin Oncol, 2015.3 (6):1329-1336. [6] [6]. Tao Y, Li Y, Zheng W, Zhao J, Guo M, Zhou Y, Qin N, Zheng J,Xu L*.Antisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cells. Canc Cell Int, 2015, 15:77. ** [7] [7]. Hu Y, Wang C, Li Y, Zhao J, Chen C, Zhou Y, Tao Y, Guo M, Qin N, Ren T, Wen Z,Xu L*. MiR-21 controlsin situexpansion of CCR6+regulatory T cells through PTEN/AKT pathway in breast cancer. Immunol Cell Biol,2015. 93(8):753-64. ** [8] [8]. Zhao J, Li Y, Hu Y, Chen C, Zhou Y, Tao Y, Guo M, Qin N,Xu L*. MicroRNAs expression profile in CCR6+regulatory T cells. Peer J, 2014. 2:e575. ** [9] Hu Y, Wang C, Li Y, Zhao J, Chen C, Zhou Y, Tao Y, Guo M, Qin N, Ren T, Wen Z, Xu L*. MiR-21 controls in situ expansion of CCR6+ regulatory T cells through PTEN/AKT pathway in breast cancer. Immunol Cell Biol, 2015 [10] Zhao J, Li Y, Hu Y, Chen C, Zhou Y, Tao Y, Guo M, Qin N, Xu L*. MicroRNAs expression profile in CCR6+ regulatory T cells. Peer J, 2014. 2:e575. [11] Li Y, Wang C, Zhou Y, Liao Z, Zhu S, Hu Y, Chen C, Luo J, Wen Z, Xu L. TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells. Canc Cell Int, 2013.13(1):90 [12] Qin A, Wen Z,Zhou Y, Li Y, Li Y, Luo J, Ren T, Xu L*.MicroRNA-126 regulates the induction and function of CD4+ Foxp3+ regulatory T cells through PI3K/AKT pathway.J Cell Mol Med. 2013;17(2):252-64. [13] Guo ZL, Wen ZK, Qin AD, Zhou Y, Ren T, Xu L. Antisense oligonucleotides treatment enhanced the recovery of acute lung injury through IL-10 secretingM2 like macrophages-induced expansion of CD4+ regulatory T cells. J Immunol, 2013,190(8):4337-48. [14] Wang M, Wang L, Ren T, Xu L, Wen Z. IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells. Cancer Biol Ther. 2013;14(2):155-63 [15] Xu L, Wen Z, Zhou Y, Liu Z, Li Q, Fei G, Luo J, Ren T. MicroRNA-7 regulated TLR9 signaling enhanced growth and metastatic potential of human lung cancer cells by altering PIK3R3/Akt pathway. Mol Bio Cell. 2013. 24(1):42-55. [16] Xu L, Zhang T, Liu Z, Li Q, Xu Z, Ren T. Critical role of Th17 cells in development of autoimmune hemolytic anemia. Exp Hematol. 2012, 40(12):994-1004.e4. [17] Xu L, Wang C, Zhou Y, Ren T, Wen Z. CpG oligonucleotides induce the differentiation of CD4(+)Th17 cells by triggering plasmacytoid dendritic cells in adoptively cell transfer immunotherapy. Immunol Lett. 2012; 142(1-2):55-63. [18] Xu L, Wang C, Wen Z, Zhou Y, Liu Z, Liang Y, Xu Z, Ren T. CpG oligodeoxynucleotides enhance the efficacy of adoptive cell transfer using tumor infiltrating lymphocytes by modifying the Th1 polarization and local infiltration of Th17 cells. Clin Dev Immunol. 2010;2010:410893. [19] Xu L, Wang C, Wen Z, Yao X, Liu Z, Li Q, Wu Z, Xu Z, Liang Y, Ren T. Selective upregulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell. Immunol letter. 2010；127（2）93-99. [20] Wen Z, Xu L, Chen X, Xu W, Yin Z, Gao X, Xiong S. Autoantibody induction by DNA-containing immune complexes requires HMGB1 with TLR2/miR-155 pathway. J Immunol, 2013. 190(11):5411-22. [21] Wen Z, Xu L, Xu W, Yin Z, Gao X, Xiong S.Interleukin-17 expression positively correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA antibody production in a lupus model induced by activated lymphocyte derived DNA.PLoS One. 2013;8(3):e58161. |
